Penserra Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-535	Closed	-$21K	–	1456
2021 Q3	$21K	Buy	535 +5	+0.9%	+$196	﹤0.01%	1237
2021 Q2	$22K	Buy	530 +10	+2%	+$415	﹤0.01%	1126
2021 Q1	$32K	Sell	520 -10	-2%	-$615	﹤0.01%	891
2020 Q4	$37K	Buy	+530	New	+$37K	﹤0.01%	739